Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Zepbound (Injectable) Zepbound (tirzepatide) injectable, a FDA-approved dual GIP and GLP-1 receptor agonist, taken once a week using single use vials and insulin syringes
Not all GLP-1 medications are the same As of April 2026, the most popular GLP-1 medications approved by the Food and Drug Administration include semaglutide, sold under the brand names Wegovy, Ozempic and Rybelsus
Book your primary care appointment today and take a proactive step toward better health
Bundle & Save Discount applies automatically at checkout once your cart subtotal hits the tier
In addition to being highly effective for weight loss, semaglutide and tirzepatide are considered very safe
Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients
US$ 29.03
US$ 27.42
US$ 26.00
US$ 25.11
US$ 24.32
US$ 22.45
US$ 27.77
